Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Sativex(®) in multiple sclerosis spasticity: a cost-effectiveness model.
IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
The risk of Bipolar Disorders in Multiple Sclerosis.
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
Immune surveillance in multiple sclerosis patients treated with natalizumab.
Oral Agent Outcomes
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
DYNACIN (MINOCYCLINE)
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Axonal transport analysis using Multitemporal Association Tracking.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.

Pages